Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Maria Carozzi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Epidemiologia E Prevenzione|September 26, 2015
hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi)Francesca Maria Carozzi, Anna Iossa, Aurora Scalisi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
Plos One|May 18, 2021
Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samplesMichela Baccini, Emilia Rocco, Irene Paganini, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be AddressedMario Mascalchi, Giulia Picozzi, Donella Puliti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2013
Four-year results of low-dose CT screening and nodule management in the ITALUNG trialAndrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, et al.
Cancer Cytopathology|November 3, 2020
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening populationMaria Benevolo, Pamela Mancuso, Elena Allia, et al.
Cancer Cytopathology|March 14, 2020
Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening populationMaria Benevolo, Pamela Mancuso, Elena Allia, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2009
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosisFrancesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, et al.
American Journal of Clinical Pathology|October 6, 2005
Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingFrancesca Maria Carozzi, Annarosa Del Mistro, Massimo Confortini, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Epidemiologia E Prevenzione|September 26, 2015
hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi)Francesca Maria Carozzi, Anna Iossa, Aurora Scalisi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factorsDonella Puliti, Mario Mascalchi, Francesca Maria Carozzi, et al.
Plos One|May 18, 2021
Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samplesMichela Baccini, Emilia Rocco, Irene Paganini, et al.
Cancers|June 27, 2024
Baseline Cell-Free DNA Can Predict Malignancy of Nodules Observed in the ITALUNG Screening TrialSimonetta Bisanzi, Donella Puliti, Giulia Picozzi, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Lung Cancer Screening with Low-Dose CT: What We Have Learned in Two Decades of ITALUNG and What Is Yet to Be AddressedMario Mascalchi, Giulia Picozzi, Donella Puliti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2013
Four-year results of low-dose CT screening and nodule management in the ITALUNG trialAndrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, et al.
Cancer Cytopathology|November 3, 2020
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening populationMaria Benevolo, Pamela Mancuso, Elena Allia, et al.
Cancer Cytopathology|March 14, 2020
Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening populationMaria Benevolo, Pamela Mancuso, Elena Allia, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2009
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosisFrancesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, et al.
American Journal of Clinical Pathology|October 6, 2005
Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening SettingFrancesca Maria Carozzi, Annarosa Del Mistro, Massimo Confortini, et al.
Pageof 3